A bezárási hatásfok növelésének lehetocombining double acute accentségei liposzómába zárt lomefloxacinnál

Translated title of the contribution: Methods to increase the encapsulation efficiency for liposomal drugs

Nóra Kaszás, M. Budai, Lívia Budai, P. Gróf, Andreas Zimmer, I. Klebovich

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Liposomes as drug delivery systems - in comparison to the traditional dosage forms - offer the advantage of the targeted drug delivery and as a consequence, reduction of the side effects. In case of fluoroquinolone antibiotics, such as lomefloxacin, the liposomal encapsulation of the active ingredient can result in an enhancement of its therapeutic efficacy against intracellular bacteria. The aim to improve the liposomal encapsulation efficiency of drugs - which is one of the main factors influencing the therapeutic effect of vesicular dosage forms - is one of the important challenges in the field of pharmaceutical technology. In our experiments we prepared lomefloxacin containing multilamellar vesicles from various lipids using different hydrating solutions. We intended to study the effect of lipid composition, cholesterol content and surface charge of liposomes on the encapsulation efficiency of lomefloxacin. Our results can contribute to the rational design of fluoroquinolone containing liposomal drugs.

Original languageHungarian
Pages (from-to)69-74
Number of pages6
JournalActa Pharmaceutica Hungarica
Volume78
Issue number2
Publication statusPublished - 2008

Fingerprint

Fluoroquinolones
Dosage Forms
Liposomes
Pharmaceutical Technology
Pharmaceutical Preparations
Lipids
Therapeutic Uses
Drug Delivery Systems
Cholesterol
Anti-Bacterial Agents
Bacteria
lomefloxacin
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

A bezárási hatásfok növelésének lehetocombining double acute accentségei liposzómába zárt lomefloxacinnál. / Kaszás, Nóra; Budai, M.; Budai, Lívia; Gróf, P.; Zimmer, Andreas; Klebovich, I.

In: Acta Pharmaceutica Hungarica, Vol. 78, No. 2, 2008, p. 69-74.

Research output: Contribution to journalArticle

@article{41024a2b888f4173914f5f8d94a2712e,
title = "A bez{\'a}r{\'a}si hat{\'a}sfok n{\"o}vel{\'e}s{\'e}nek lehetocombining double acute accents{\'e}gei liposz{\'o}m{\'a}ba z{\'a}rt lomefloxacinn{\'a}l",
abstract = "Liposomes as drug delivery systems - in comparison to the traditional dosage forms - offer the advantage of the targeted drug delivery and as a consequence, reduction of the side effects. In case of fluoroquinolone antibiotics, such as lomefloxacin, the liposomal encapsulation of the active ingredient can result in an enhancement of its therapeutic efficacy against intracellular bacteria. The aim to improve the liposomal encapsulation efficiency of drugs - which is one of the main factors influencing the therapeutic effect of vesicular dosage forms - is one of the important challenges in the field of pharmaceutical technology. In our experiments we prepared lomefloxacin containing multilamellar vesicles from various lipids using different hydrating solutions. We intended to study the effect of lipid composition, cholesterol content and surface charge of liposomes on the encapsulation efficiency of lomefloxacin. Our results can contribute to the rational design of fluoroquinolone containing liposomal drugs.",
author = "N{\'o}ra Kasz{\'a}s and M. Budai and L{\'i}via Budai and P. Gr{\'o}f and Andreas Zimmer and I. Klebovich",
year = "2008",
language = "Hungarian",
volume = "78",
pages = "69--74",
journal = "Acta Pharmaceutica Hungarica",
issn = "0001-6659",
publisher = "Magyar Gyogyszereszeti Tarsasag",
number = "2",

}

TY - JOUR

T1 - A bezárási hatásfok növelésének lehetocombining double acute accentségei liposzómába zárt lomefloxacinnál

AU - Kaszás, Nóra

AU - Budai, M.

AU - Budai, Lívia

AU - Gróf, P.

AU - Zimmer, Andreas

AU - Klebovich, I.

PY - 2008

Y1 - 2008

N2 - Liposomes as drug delivery systems - in comparison to the traditional dosage forms - offer the advantage of the targeted drug delivery and as a consequence, reduction of the side effects. In case of fluoroquinolone antibiotics, such as lomefloxacin, the liposomal encapsulation of the active ingredient can result in an enhancement of its therapeutic efficacy against intracellular bacteria. The aim to improve the liposomal encapsulation efficiency of drugs - which is one of the main factors influencing the therapeutic effect of vesicular dosage forms - is one of the important challenges in the field of pharmaceutical technology. In our experiments we prepared lomefloxacin containing multilamellar vesicles from various lipids using different hydrating solutions. We intended to study the effect of lipid composition, cholesterol content and surface charge of liposomes on the encapsulation efficiency of lomefloxacin. Our results can contribute to the rational design of fluoroquinolone containing liposomal drugs.

AB - Liposomes as drug delivery systems - in comparison to the traditional dosage forms - offer the advantage of the targeted drug delivery and as a consequence, reduction of the side effects. In case of fluoroquinolone antibiotics, such as lomefloxacin, the liposomal encapsulation of the active ingredient can result in an enhancement of its therapeutic efficacy against intracellular bacteria. The aim to improve the liposomal encapsulation efficiency of drugs - which is one of the main factors influencing the therapeutic effect of vesicular dosage forms - is one of the important challenges in the field of pharmaceutical technology. In our experiments we prepared lomefloxacin containing multilamellar vesicles from various lipids using different hydrating solutions. We intended to study the effect of lipid composition, cholesterol content and surface charge of liposomes on the encapsulation efficiency of lomefloxacin. Our results can contribute to the rational design of fluoroquinolone containing liposomal drugs.

UR - http://www.scopus.com/inward/record.url?scp=47149108536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47149108536&partnerID=8YFLogxK

M3 - Article

C2 - 18807386

AN - SCOPUS:47149108536

VL - 78

SP - 69

EP - 74

JO - Acta Pharmaceutica Hungarica

JF - Acta Pharmaceutica Hungarica

SN - 0001-6659

IS - 2

ER -